Park Avenue Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.35M | Sell |
|
|||||
|
2025
Q2 | $3.66M | Buy |
|
|||||
|
2025
Q1 | $3.01M | Buy |
|
|||||
|
2024
Q4 | $1.78M | Sell |
|
|||||
|
2024
Q3 | $2.46M | Sell |
|
|||||
|
2024
Q2 | $2.82M | Buy |
|
|||||
|
2024
Q1 | $2.82M | Buy |
|
|||||
|
2023
Q4 | $2.25M | Buy |
|
|||||
|
2023
Q3 | $1.59M | Buy |
|
|||||
|
2023
Q2 | $1.44M | Buy |
|
|||||
|
2023
Q1 | $1.27M | Buy |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $854K | Buy |
|
|||||
|
2022
Q2 | $1.55M | Buy |
|
|||||
|
2022
Q1 | $1.25M | Buy |
|
|||||
|
2021
Q4 | $956K | Buy |
|
|||||
|
2021
Q3 | $454K | Buy |
|
|||||
|
2021
Q2 | $371K | Buy |
|
|||||
|
2021
Q1 | $273K | Sell |
|
|||||
|
2020
Q4 | $293K | Sell |
|
|||||
|
2020
Q3 | $609K | Sell |
|
|||||
|
2020
Q2 | $699K | Sell |
|
|||||
|
2020
Q1 | $678K | Buy |
|
|||||
|
2019
Q4 | $764K | Buy |
|
|||||
|
2019
Q3 | $598K | Sell |
|
|||||
|
2019
Q2 | $575K | Buy |
|
|||||
|
2019
Q1 | $582K | Sell |
|
|||||
|
2018
Q4 | $556K | Sell |
|
|||||
|
2018
Q3 | $627K | Buy |
|
|||||
|
2018
Q2 | $603K | Buy |
|
|||||
|
2018
Q1 | $289K | Buy |
|
|||||
|
2017
Q4 | $238K | Sell |
|
|||||
|
2017
Q3 | $479K | Buy |
|
|||||
|
2017
Q2 | $369K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $239K | Buy |
|
|||||
|
2016
Q3 | $214K | Buy |
|